This is a synthetic peptide designed for use in combination with anti-PRKRA antibody (Catalog #: ARP40476_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
PRKRA Peptide, AV120107 Peptide, PRK Peptide, Pact Peptide, RAX Peptide, lear Peptide, DYT16 Peptide, PACT Peptide, im:7151758 Peptide, zgc:162619 Peptide, dyt16 Peptide, pact Peptide, prkra-a Peptide, prkra-b Peptide, rax Peptide, rbpa Peptide, protein activator of interferon induced protein kinase EIF2AK2 Peptide, protein kinase, interferon inducible double stranded RNA dependent activator Peptide, protein kinase, interferon-inducible double stranded RNA dependent activator Peptide, protein activator of interferon induced protein kinase EIF2AK2 L homeolog Peptide, PRKRA Peptide, Prkra Peptide, prkra Peptide, prkra.L Peptide
Sujet
PRKRA contains 3 DRBM (double-stranded RNA-binding) domains. It appears to have a pro-apoptotic function that may be suppressed in the presence of growth factor and activates EIF2AK2 in absence of double stranded RNA (dsRNA).
Alias Symbols: HSD14, PACT, RAX, DYT16
Protein Interaction Partner: EIF2AK2,COPS6,DICER1,EIF2AK2,EIF2C2,GDF9,PRKRA,RB1,SETDB1,TARBP2,TIRAP,TP53,COPS6,EIF2AK2,GDF9,IGF2BP1,PRKRA,PRPSAP1,RB1,RPL36,SETDB1,SYNCRIP,TP53